Arecor Therapeutics plc (AREC.L)
GBp 38.0
(3.68%)
GBp 38.0
(3.68%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 338 Thousand GBP | 17.36% |
| 2022 | 288 Thousand GBP | 24.68% |
| 2021 | 231 Thousand GBP | -88.42% |
| 2020 | 1.99 Million GBP | 3204.05% |
| 2019 | 60.39 Thousand GBP | -72.71% |
| 2018 | 221.27 Thousand GBP | -66.48% |
| 2017 | 660.09 Thousand GBP | 14.58% |
| 2016 | 576.12 Thousand GBP | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 111 Thousand GBP | 0.0% |
| 2024 Q1 | - GBP | -100.0% |
| 2023 Q4 | 338 Thousand GBP | 53.64% |
| 2023 FY | 338 Thousand GBP | 17.36% |
| 2023 Q3 | 220 Thousand GBP | 31.74% |
| 2023 Q2 | 167 Thousand GBP | 227.45% |
| 2023 Q1 | 51 Thousand GBP | -82.29% |
| 2022 FY | 288 Thousand GBP | 24.68% |
| 2022 Q4 | 288 Thousand GBP | 234.88% |
| 2022 Q3 | 86 Thousand GBP | -49.11% |
| 2022 Q2 | 169 Thousand GBP | 302.38% |
| 2022 Q1 | 42 Thousand GBP | -81.82% |
| 2021 Q3 | 105 Thousand GBP | -64.18% |
| 2021 FY | 231 Thousand GBP | -88.42% |
| 2021 Q1 | 168.31 Thousand GBP | -91.56% |
| 2021 Q2 | 293.12 Thousand GBP | 74.15% |
| 2021 Q4 | 231 Thousand GBP | 120.0% |
| 2020 Q3 | 1.89 Million GBP | 583.26% |
| 2020 Q2 | 276.61 Thousand GBP | 0.0% |
| 2020 Q1 | - GBP | 0.0% |
| 2020 FY | 1.99 Million GBP | 3204.05% |
| 2020 Q4 | 1.99 Million GBP | 5.57% |
| 2019 FY | 60.39 Thousand GBP | -72.71% |
| 2018 FY | 221.27 Thousand GBP | -66.48% |
| 2017 FY | 660.09 Thousand GBP | 14.58% |
| 2016 FY | 576.12 Thousand GBP | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|